Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants
This study has been terminated.
( difficulty in recruiting subjects )
Study NCT00265005   Information provided by University of Louisville

First Received on December 12, 2005.   Last Updated on June 17, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Vascular Diseases
Interventions listed in this trial
alteplase
Additional drug interventions recognized in this trial
Tissue Plasminogen Activator
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Louisville
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services